Sarah Cannon Research Institute
Irving Solano is a skilled Site Regulatory Specialist at SCRI Oncology Partners since April 2023, providing regulatory support and managing document systems for clinical studies. Previously, as a Clinical Research Data Coordinator for oncology trials, significant achievements included ensuring protocol compliance and managing patient data effectively. At Instituto Nacional de Perinatología from May 2021 to February 2022, contributions included analyzing clinical data and maintaining HPLC equipment per industry standards. Earlier experience as a Quality Management Systems Specialist at LANISAF involved developing QMS documentation and conducting internal audits for ISO compliance. Irving holds a Bachelor's degree in Biological Pharmaceutical Chemistry from Facultad de Estudios Superiores Zaragoza, completed in 2020.
This person is not in the org chart
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.